FDA NDC Directory · JSON-LD · Markdown
NDC 81927-111 · HUMAN PRESCRIPTION DRUG · INJECTION
| Labeler / Manufacturer | Shorla Oncology Inc. |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA214809 |
| Dosage form / route | INJECTION · INTRAVENOUS |
| Active ingredients | NELARABINE (5 mg/mL) |
| Marketing started | 20230315 |
| Package count | 2 |
Source: openFDA. Public-domain (CC0).